Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization. Issue 41 (22nd September 2016)

• Record Type: Journal Article
• Authors: Penaloza-MacMaster, Pablo; Alayo, Quazim A.; Ra, Joshua; Provine, Nicholas M.; Larocca, Rafael; Lee, Benjamin; Barouch, Dan H.
• Is Part Of: Vaccine. Volume 34:Issue 41(2016)
• Page Start: 4955
• Page End: 4963
• Publication Date: 2016-09-22
• Subjects: Adenovirus -- Vector -- PD-1 -- HIV-1; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2016.08.048
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: T cells are an important component of immune responses, and their function is influenced by their expression of inhibitory receptors. Immunization with alternative serotype adenovirus (Ad) vectors induces highly functional T cell responses with lower programmed cell death 1 (PD-1) expression and increased boostability relative to Ad5 vectors. However, a detailed phenotypic characterization of other inhibitory receptors is lacking, and it is unknown whether Ad5-induced CD8 T cells eventually recover function with time. In this report, we measure the expression of various inhibitory receptors and memory markers during early and late time points following vaccination with Ad5 and alternative serotype Ad vectors. CD8 T cells induced by Ad5 exhibited increased expression of the inhibitory receptor Tim-3 and showed decreased central memory differentiation as compared with alternative serotype Ad vectors, even a year following immunization. Moreover, relative to Ad5-primed mice, Ad26-primed mice exhibited substantially improved recall of SIV Gag-specific CD8 T cell responses following heterologous boosting with MVA or Ad35 vectors. We also demonstrate that low doses of Ad5 priming resulted in more boostable immune responses with lower PD-1 expression as compared to high Ad5 doses, suggesting a role for vector dose in influencing immune dysfunction following Ad5 vaccination. These data suggest that Ad5 vectors induce a long-term pattern of immune exhaustion that can be partly overcome by lowering vector dose and modulating inhibitory signals.